| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHSA1
|
AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
AQP4
|
aquaporin 4
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCOR
|
BCL6 corepressor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD4
|
bromodomain containing 4
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV3
|
caveolin 3
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCN1
|
cellular communication network factor 1
|
|
CCND1
|
cyclin D1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD19
|
CD19 molecule
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLEC14A
|
C-type lectin domain family 14, member A
|
|
CLTA
|
clathrin, light chain A
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COX2
|
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRMP1
|
collapsin response mediator protein 1
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSV
|
cathepsin V
|
|
CTTN
|
cortactin
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
DAP3
|
death associated protein 3
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCTN6
|
dynactin 6
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DES
|
desmin
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DPYSL4
|
dihydropyrimidinase-like 4
|
|
DPYSL5
|
dihydropyrimidinase-like 5
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3K
|
eukaryotic translation initiation factor 3, subunit K
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F11
|
coagulation factor XI
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FHIT
|
fragile histidine triad
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXN1
|
forkhead box N1
|
|
FOXP3
|
forkhead box P3
|
|
FSD1
|
fibronectin type III and SPRY domain containing 1
|
|
FSD1L
|
fibronectin type III and SPRY domain containing 1-like
|
|
FST
|
follistatin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GMFB
|
glia maturation factor, beta
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
HACD1
|
3-hydroxyacyl-CoA dehydratase 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HMGB1
|
high mobility group box 1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
|
JAK2
|
Janus kinase 2
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLRC4-KLRK1
|
KLRC4-KLRK1 readthrough
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LTA
|
lymphotoxin alpha
|
|
LY75
|
lymphocyte antigen 75
|
|
LY75-CD302
|
LY75-CD302 readthrough
|
|
MAEA
|
macrophage erythroblast attacher
|
|
MAP3K10
|
mitogen-activated protein kinase kinase kinase 10
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MB
|
myoglobin
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MPST
|
mercaptopyruvate sulfurtransferase
|
|
MSLN
|
mesothelin
|
|
MSTO1
|
misato 1, mitochondrial distribution and morphology regulator
|
|
MTA1
|
metastasis associated 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTN1
|
netrin 1
|
|
NUDT11
|
nudix (nucleoside diphosphate linked moiety X)-type motif 11
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PBRM1
|
polybromo 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PDPN
|
podoplanin
|
|
PIGF
|
phosphatidylinositol glycan anchor biosynthesis, class F
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLIN2
|
perilipin 2
|
|
PMP22
|
peripheral myelin protein 22
|
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRSS16
|
protease, serine, 16 (thymus)
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTCRA
|
pre T-cell antigen receptor alpha
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTN
|
pleiotrophin
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRT
|
protein tyrosine phosphatase, receptor type, T
|
|
RAD51B
|
RAD51 paralog B
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RBM45
|
RNA binding motif protein 45
|
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
RPL36A
|
ribosomal protein L36a
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SALL3
|
spalt-like transcription factor 3
|
|
SCARA3
|
scavenger receptor class A, member 3
|
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6
|
|
SETD2
|
SET domain containing 2
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SORBS1
|
sorbin and SH3 domain containing 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1
|
|
SST
|
somatostatin
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STK24
|
serine/threonine kinase 24
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR3
|
toll-like receptor 3
|
|
TMED7
|
transmembrane emp24 protein transport domain containing 7
|
|
TMED7-TICAM2
|
TMED7-TICAM2 readthrough
|
|
TMEM109
|
transmembrane protein 109
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNS4
|
tensin 4
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TYMS
|
thymidylate synthetase
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
ULBP1
|
UL16 binding protein 1
|
|
UNC5A
|
unc-5 homolog A (C. elegans)
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
|
VNN2
|
vanin 2
|
|
WDR11
|
WD repeat domain 11
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
